Teva Pharmaceutical Industries Ltd. is transitioning its stock from American Depositary Shares (ADS) to a direct listing on the NYSE.
6 reports, 5 independent
Updated Sep 14
Gone quiet
- Reports
- 6
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Teva Pharmaceutical Industries Ltd. is transitioning its stock from American Depositary Shares (ADS) to a direct listing on the NYSE.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Teva shares start trading directly on the NYSE following its transition from ADS.1 source
Market activity regarding Teva stock, including analyst rating lifts and institutional buying.1 source
Teva is moving from ADS to a direct listing on the New York Stock Exchange.1 source
Keep exploring
The entities involved
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Nothing else this week.
-
New York Stock Exchange
American stock exchange
Related events
- West Pharmaceutical Services was reported to be traded on the New York Stock Exchange (NYSE) on October 19, 2026.
- A company whose CEOs are merging is utilizing both the NYSE and Nasdaq as potential listing venues, with operations spanning Maryland and Pennsylvania.
- Stock trades occurred on the NYSE platform while filing disclosures with the SEC.
- Truist Financial raised its target price on Teva Pharmaceutical Industries Ltd. stock.
- Range Resources Corporation is reporting its financial results on the New York Stock Exchange.